Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy

LMS Boeve; Paul Verhagen; AN Vis

doi:10.1016/j.eururo.2018.11.008

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy

LMS Boeve, Paul Verhagen, AN Vis

Urology

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	E71-E72
Journal	European Urology
Volume	75
Issue number	3
DOIs	https://doi.org/10.1016/j.eururo.2018.11.008
Publication status	Published - 2019

Research programs

EMC MM-03-49-01

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.eururo.2018.11.008

http://hdl.handle.net/1765/115241

Cite this

Boeve, LMS., Verhagen, P., & Vis, AN. (2019). Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy. European Urology, 75(3), E71-E72. https://doi.org/10.1016/j.eururo.2018.11.008

Boeve, LMS ; Verhagen, Paul ; Vis, AN. / Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy. In: European Urology. 2019 ; Vol. 75, No. 3. pp. E71-E72.

@article{37876b2727f34de0aec5fcf5491dd2b4,

title = "Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy",

author = "LMS Boeve and Paul Verhagen and AN Vis",

year = "2019",

doi = "10.1016/j.eururo.2018.11.008",

language = "Undefined/Unknown",

volume = "75",

pages = "E71--E72",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "3",

}

Boeve, LMS, Verhagen, P & Vis, AN 2019, 'Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy', European Urology, vol. 75, no. 3, pp. E71-E72. https://doi.org/10.1016/j.eururo.2018.11.008

Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy. / Boeve, LMS; Verhagen, Paul; Vis, AN.
In: European Urology, Vol. 75, No. 3, 2019, p. E71-E72.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy

AU - Boeve, LMS

AU - Verhagen, Paul

AU - Vis, AN

PY - 2019

Y1 - 2019

U2 - 10.1016/j.eururo.2018.11.008

DO - 10.1016/j.eururo.2018.11.008

M3 - Article

C2 - 30463663

SN - 0302-2838

VL - 75

SP - E71-E72

JO - European Urology

JF - European Urology

IS - 3

ER -

Boeve LMS, Verhagen P, Vis AN. Reply to Ashwin Shinde, Richard Li, Arya Amini, and Scott Glaser's Letter to the Editor re: Liselotte MS Boeve, Maarten CCM Hulshof, Andre N. Vis, et al. Effect on Survival of Androgen Deprivation Therapy Alone Compared to Androgen Deprivation Therapy Combined with Concurrent Radiation Therapy to the Prostate in Patients with Primary Bone Metastatic Prostate Cancer in a Prospective Randomised Clinical Trial: Data from the HORRAD Trial. Eur Urol 2019; 75: 410-8 Future Steps for Definitive Therapy. European Urology. 2019;75(3):E71-E72. doi: 10.1016/j.eururo.2018.11.008